Scientific Advice

1. lut 28, 2025

What Does the 'Scientific Advice’ Mean?

Scientific advice refers to the formal process of seeking guidance from regulatory authorities or expert committees during drug development. This consultation typically occurs before or during clinical trials to discuss the proposed development strategy, study designs, and regulatory requirements.

The primary goal of scientific advice is to enhance the efficiency and quality of drug development by addressing potential issues early. It provides sponsors with valuable insights into regulatory expectations, helping to optimize their development programs and increase the likelihood of successful marketing authorization applications.

Why Is the 'Scientific Advice’ Important in Clinical Research?

Scientific advice is crucial in clinical research as it facilitates a proactive dialogue between sponsors and regulatory authorities. This communication helps align development strategies with regulatory expectations, potentially reducing costly delays and increasing the chances of successful drug approval.

Furthermore, scientific advice enables researchers to address complex scientific and regulatory challenges early in the development process. By incorporating regulatory input at critical stages, sponsors can make informed decisions, optimize study designs, and allocate resources more effectively, ultimately benefiting patients through improved drug development efficiency.

Good Practices and Procedures

1. Prepare a comprehensive briefing package outlining key development questions, proposed strategies, and supporting data well in advance of the scientific advice meeting.
2. Engage multidisciplinary experts, including clinicians, statisticians, and regulatory affairs specialists, to critically review and refine the scientific advice request.
3. Conduct mock scientific advice sessions with internal or external advisors to anticipate potential questions and refine responses.
4. Follow up on scientific advice outcomes by developing a detailed implementation plan and timeline for incorporating regulatory recommendations into the development program.
5. Consider seeking follow-up scientific advice if significant changes to the development plan occur or new data emerge that may impact previous recommendations.

Related Terms

• Training Compliance
• Primary Endpoint
• Clinical Operations